Font Size: a A A
Keyword [Cereblon]
Result: 1 - 17 | Page: 1 of 1
1. Association Of Cereblon Gene Expression With Lenalidomide Efficacy In Treating POEMS Syndrome
2. Application Of MLPA In Detection Of Chromosome Abnormalities Of Myelodysplastic Syndromes Long-term Outcome Of Thalidomide And Cyclosporine InPatients With IPSS Low/intermediate-1 MyelodysplasticSyndrome
3. The Clinical Significance Of Cereblon Expression In Multiple Myeloma
4. Lenalidomide Affect The Expression Levels Of Cereblon For Multiple Myeloma Cell Line RPMI8226
5. The Clinical Significance Of Serum Microrna, Long Non-coding RNA And CRBN Protein In Multiple Myeloma
6. The Clinical Significance Of Cereblon Expression In Chronic Myeloproliferative Neoplasma
7. SCFFbxo7 Ubiquitin Ligase Targets Cereblon To Limit The Anti-myeloma Activity Of IMiDs
8. CRL4 Antagonizes SCFFbxo7-mediated Turnover Of Cereblon And BK Channel To Regulate Learning And Memory
9. Cereblon Controls T-lymphocyte Homeostasis And Activation
10. Cereblon Suppresses LPS-induced Inflammatory Response And Apoptosis Through Promoting The Ubiquitination And Degradation Of C-Jun
11. Cereblon Expression In Diffuse Large B-cell Lymphomaand Its Relationship With Clinical Features And Prognosis
12. Apoptotic Effect Of Pomalidomide On MM1.S In Multiple Myeloma Cells And Its Regulation On Cereblon Expression
13. Experimental Study On The Effect Of Pomalidomide On Unfolded Protein Response And Cereblon In MM1.S Cells Of Multiple Myeloma
14. Mechanistic Study Of The Regulation Of Immunomodulatory Drugs And Cereblon On The Ubiquitination And Degradation Of The Downstream Proteins
15. The Molecular Mechanism Of Neurite Outgrowth Regulated By Cereblon
16. Cereblon Modulator CC-885 Induces CRBN-dependent Ubiquitination And Degradation Of CDK4 In Multiple Myeloma
17. Design,Synthesis And Biological Activity Evaluations Of Novel Immunodulatory Drugs（IMiDs）
  <<First  <Prev  Next>  Last>>  Jump to